Matches in Nanopublications for { ?s ?p "[After successful remission induction with single-agent chemotherapy (VM-26) and subsequent sustained remission for 12 months with alternating VM-26 and VP-16-213, lineage switch to ALL (FAB L1) occurred.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP400834.RAQVrQ1s-lTclE_d5NtoHr_5Y_iuHKA_bH92fSo8_HzZ8130_assertion description "[After successful remission induction with single-agent chemotherapy (VM-26) and subsequent sustained remission for 12 months with alternating VM-26 and VP-16-213, lineage switch to ALL (FAB L1) occurred.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400834.RAQVrQ1s-lTclE_d5NtoHr_5Y_iuHKA_bH92fSo8_HzZ8130_provenance.
- NP1296543.RAUqImD8ccPX3QTgSDG6r0AfBRY4ZywFIUSZbFBJNIrAU130_assertion description "[After successful remission induction with single-agent chemotherapy (VM-26) and subsequent sustained remission for 12 months with alternating VM-26 and VP-16-213, lineage switch to ALL (FAB L1) occurred.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1296543.RAUqImD8ccPX3QTgSDG6r0AfBRY4ZywFIUSZbFBJNIrAU130_provenance.
- NP394264.RA2xUo3OxNZQoImecVg8kyz2tufucaAQMZoVf4vwejb2E130_assertion description "[After successful remission induction with single-agent chemotherapy (VM-26) and subsequent sustained remission for 12 months with alternating VM-26 and VP-16-213, lineage switch to ALL (FAB L1) occurred.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP394264.RA2xUo3OxNZQoImecVg8kyz2tufucaAQMZoVf4vwejb2E130_provenance.